TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T06320	Galectin 3	B0SWD9	5-(beta-D-Galactopyranosyl)-4-methyl-2-(4-tert-Butylphenyl)sulfonylaminothiazole	Investigative	44586921	C21H30N2O7S2	486.6	CC1=C(SC(=N1)NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	B0SWD9	5-(beta-D-Galactopyranosyl)-4-methyl-2-(4-tert-Butylphenyl)sulfonylaminothiazole	Investigative	44586921	C21H30N2O7S2	486.6	CC1=C(SC(=N1)NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 3	B18HAB	(2S,3R,4S,5R,6R)-2-((2R,3S,4R,5R,6S)-4,5-Dihydroxy-2-(hydroxymethyl)-6-((1-((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methylthio)-tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586985	C21H35N3O15S	601.6	C1=C(N=NN1[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)CO)O)O)O)CS[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O	IC50 = 300000 nM	Non binder
T06320	Galectin 1	B18HAB	(2S,3R,4S,5R,6R)-2-((2R,3S,4R,5R,6S)-4,5-Dihydroxy-2-(hydroxymethyl)-6-((1-((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methylthio)-tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586985	C21H35N3O15S	601.6	C1=C(N=NN1[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)CO)O)O)O)CS[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O	IC50 = 600000 nM	Non binder
T06320	Galectin 3	B1ZC6T	(E)-Methyl 4-(beta-D-galactopyranosyl)-but-2-enoate	Investigative	44586862	C11H18O7	262.26	COC(=O)/C=C/C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	B1ZC6T	(E)-Methyl 4-(beta-D-galactopyranosyl)-but-2-enoate	Investigative	44586862	C11H18O7	262.26	COC(=O)/C=C/C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 3	B2SB6E	5-(beta-D-Galactopyranosyl)-4-methyl-2-4-nitrobenzylaminothiazole	Investigative	44586924	C18H23N3O7S	425.5	CC1=C(SC(=N1)NCC2=CC=C(C=C2)[N+](=O)[O-])C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	B2SB6E	5-(beta-D-Galactopyranosyl)-4-methyl-2-4-nitrobenzylaminothiazole	Investigative	44586924	C18H23N3O7S	425.5	CC1=C(SC(=N1)NCC2=CC=C(C=C2)[N+](=O)[O-])C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	B51WNS	(2S,3R,4S,5R,6R)-2-((2R,3S,4R,5R,6S)-6-(6-((2R,3S,4S,5R,6S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-ylthio)hexa-2,4-diynylthio)-4,5-dihydroxy-2-(hydroxymethyl)-tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586986	C30H46O20S2	790.8	C(C#CC#CCS[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO)O[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)CO)O)O)O)O)O)S[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O	IC50 = 300000 nM	Non binder
T06320	Galectin 1	B5EFI4	(2S,3R,4S,5R,6R)-2-((2R,3S,4R,5R,6S)-6-((1-((2S,3S,4S,5R,6S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methylthio)-4,5-dihydroxy-2-(hydroxymethyl)-tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44587043	C27H45N3O20S	763.7	C1=C(N=NN1[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O)O)O)O)CS[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)O)O	IC50 = 300000 nM	Non binder
T06320	Galectin 3	B5SUX1	5-(beta-D-Galactopyranosyl)-4-methyl-2-phenylacetamidothiazole	Investigative	44586953	C19H24N2O6S	408.5	CC1=C(SC(=N1)NC(=O)CC2=CC=CC=C2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	B5SUX1	5-(beta-D-Galactopyranosyl)-4-methyl-2-phenylacetamidothiazole	Investigative	44586953	C19H24N2O6S	408.5	CC1=C(SC(=N1)NC(=O)CC2=CC=CC=C2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	B6EM3W	(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(3-(4-(3-((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-ylthio)prop-1-ynyl)phenyl)prop-2-ynylthio)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586990	C24H30O10S2	542.6	C1=CC(=CC=C1C#CCS[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)C#CCS[C@@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 3	B6EM3W	(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(3-(4-(3-((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-ylthio)prop-1-ynyl)phenyl)prop-2-ynylthio)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586990	C24H30O10S2	542.6	C1=CC(=CC=C1C#CCS[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)C#CCS[C@@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	B7B5PF	2-p-Anisamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586951	C19H24N2O7S	424.5	CC1=C(SC(=N1)NC(=O)C2=CC=C(C=C2)OC)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	B7B5PF	2-p-Anisamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586951	C19H24N2O7S	424.5	CC1=C(SC(=N1)NC(=O)C2=CC=C(C=C2)OC)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 3	B81GSA	5-(beta-D-Galactopyranosyl)-4-methyl-2-(2-chloro-phenyl)sulfonylaminothiazole	Investigative	44586895	C17H21ClN2O7S2	464.9	CC1=C(SC(=N1)NS(=O)(=O)C2=CC=CC=C2Cl)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	B81GSA	5-(beta-D-Galactopyranosyl)-4-methyl-2-(2-chloro-phenyl)sulfonylaminothiazole	Investigative	44586895	C17H21ClN2O7S2	464.9	CC1=C(SC(=N1)NS(=O)(=O)C2=CC=CC=C2Cl)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	B8NM0R	5-(beta-D-Galactopyranosyl)-4-methyl-2-benzylaminothiazole	Investigative	44586923	C18H24N2O5S	380.5	CC1=C(SC(=N1)NCC2=CC=CC=C2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	B8NM0R	5-(beta-D-Galactopyranosyl)-4-methyl-2-benzylaminothiazole	Investigative	44586923	C18H24N2O5S	380.5	CC1=C(SC(=N1)NCC2=CC=CC=C2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 3	B94JQT	2-Benzamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586925	C18H22N2O6S	394.4	CC1=C(SC(=N1)NC(=O)C2=CC=CC=C2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	B94JQT	2-Benzamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586925	C18H22N2O6S	394.4	CC1=C(SC(=N1)NC(=O)C2=CC=CC=C2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	B95BSO	(2S,3R,4S,5R,6R)-2-((2R,3S,4R,5R,6S)-4,5-Dihydroxy-2-(hydroxymethyl)-6-(prop-2-ynylthio)-tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586987	C15H24O10S	396.4	C#CCS[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O	IC50 = 300000 nM	Non binder
T06320	Galectin 1	B95BSO	(2S,3R,4S,5R,6R)-2-((2R,3S,4R,5R,6S)-4,5-Dihydroxy-2-(hydroxymethyl)-6-(prop-2-ynylthio)-tetrahydro-2H-pyran-3-yloxy)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586987	C15H24O10S	396.4	C#CCS[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O	IC50 = 600000 nM	Non binder
T06320	Galectin 3	B9U2GP	Chembl4207339	Investigative	145975452	C18H24N4O9S	472.5	CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N2C=C(N=N2)CO[C@H]3[C@H]([C@H](O[C@H]([C@@H]3O)OC)CO)O	EC50 = 205000 nM	Non binder
T06320	Galectin 3	BB2U1Q	(2R,3R,4R,5R,6S)-2-(Hydroxymethyl)-6-(2-(4-methoxyphenyl)allyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586864	C16H22O6	310.34	COC1=CC=C(C=C1)C(=C)C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	BB2U1Q	(2R,3R,4R,5R,6S)-2-(Hydroxymethyl)-6-(2-(4-methoxyphenyl)allyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586864	C16H22O6	310.34	COC1=CC=C(C=C1)C(=C)C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BC34IN	beta-Lactose	Investigative	6134	C12H22O11	342.3	C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O	IC50 = 800000 nM	Non binder
T06320	Galectin 1	BC34IN	beta-Lactose	Investigative	6134	C12H22O11	342.3	C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O	IC50 = 800000 nM	Non binder
T06320	Galectin 3	BC3X0O	5-(beta-D-Galactopyranosyl)-2-methylcarbamate-4-methylthiazole	Investigative	44586984	C13H20N2O7S	348.37	CC1=C(SC(=N1)NC(=O)OC)C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	BC3X0O	5-(beta-D-Galactopyranosyl)-2-methylcarbamate-4-methylthiazole	Investigative	44586984	C13H20N2O7S	348.37	CC1=C(SC(=N1)NC(=O)OC)C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BC8LD5	5-(beta-D-Galactopyranosyl)-4-methyl-2-(b-naphthyl)sulfonylaminothiazole	Investigative	44586894	C21H24N2O7S2	480.6	CC1=C(SC(=N1)NS(=O)(=O)C2=CC3=CC=CC=C3C=C2)C[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	BC8LD5	5-(beta-D-Galactopyranosyl)-4-methyl-2-(b-naphthyl)sulfonylaminothiazole	Investigative	44586894	C21H24N2O7S2	480.6	CC1=C(SC(=N1)NS(=O)(=O)C2=CC3=CC=CC=C3C=C2)C[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BF6A1O	(2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-((1-((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methylthio)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44587045	C15H25N3O10S	439.4	C1=C(N=NN1[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)CO)O)O)O)CS[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	BF6A1O	(2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-((1-((2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methylthio)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44587045	C15H25N3O10S	439.4	C1=C(N=NN1[C@@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)CO)O)O)O)CS[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BFO8S0	(2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-(prop-2-ynylthio)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586988	C9H14O5S	234.27	C#CCS[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	BFO8S0	(2R,3R,4S,5R,6S)-2-(Hydroxymethyl)-6-(prop-2-ynylthio)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586988	C9H14O5S	234.27	C#CCS[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BH93RY	5-(beta-D-Galactopyranosyl)-4-methyl-2-(2,5-dibromophenyl)sulfonylaminothiazole	Investigative	44586922	C17H20Br2N2O7S2	588.3	CC1=C(SC(=N1)NS(=O)(=O)C2=C(C=CC(=C2)Br)Br)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	BH93RY	5-(beta-D-Galactopyranosyl)-4-methyl-2-(2,5-dibromophenyl)sulfonylaminothiazole	Investigative	44586922	C17H20Br2N2O7S2	588.3	CC1=C(SC(=N1)NS(=O)(=O)C2=C(C=CC(=C2)Br)Br)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BHM1N3	(2S,3R,4R,5R,6R)-2-Cinnamyl-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586861	C15H20O5	280.32	C1=CC=C(C=C1)/C=C/C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	BHM1N3	(2S,3R,4R,5R,6R)-2-Cinnamyl-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586861	C15H20O5	280.32	C1=CC=C(C=C1)/C=C/C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BKH79Y	5-(beta-D-Galactopyranosyl)-4-methyl-2-(4-bromophenyl)sulfonylaminothiazole	Investigative	44586893	C17H21BrN2O7S2	509.4	CC1=C(SC(=N1)NS(=O)(=O)C2=CC=C(C=C2)Br)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	BKH79Y	5-(beta-D-Galactopyranosyl)-4-methyl-2-(4-bromophenyl)sulfonylaminothiazole	Investigative	44586893	C17H21BrN2O7S2	509.4	CC1=C(SC(=N1)NS(=O)(=O)C2=CC=C(C=C2)Br)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BKJA81	2-Acetamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586954	C13H20N2O6S	332.37	CC1=C(SC(=N1)NC(=O)C)C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	BKJA81	2-Acetamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586954	C13H20N2O6S	332.37	CC1=C(SC(=N1)NC(=O)C)C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	BL49IE	(2S,3R,4R,5R,6R)-2-((12S,14R,15R,16R,17R,E)-3-((E)-3-((2S,3R,4R,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)prop-1-enyl)cinnamyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586863	C24H34O10	482.5	C1=CC(=CC(=C1)/C=C/C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)/C=C/C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 3	BL49IE	(2S,3R,4R,5R,6R)-2-((12S,14R,15R,16R,17R,E)-3-((E)-3-((2S,3R,4R,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)prop-1-enyl)cinnamyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586863	C24H34O10	482.5	C1=CC(=CC(=C1)/C=C/C[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)/C=C/C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	BPE2Q6	(2R,3R,4R,5R,6S)-2-(Hydroxymethyl)-6-(2-(3-nitrophenyl)allyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586891	C15H19NO7	325.31	C=C(C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)C2=CC(=CC=C2)[N+](=O)[O-]	IC50 = 5000000 nM	Non binder
T06320	Galectin 3	BPE2Q6	(2R,3R,4R,5R,6S)-2-(Hydroxymethyl)-6-(2-(3-nitrophenyl)allyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586891	C15H19NO7	325.31	C=C(C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)C2=CC(=CC=C2)[N+](=O)[O-]	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BSU02V	[(2S,3R,4R,5R,6R)-2-[3-[4-[3-[(2R,3S,4S,5R,6S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]sulfanylprop-1-ynyl]phenyl]prop-2-ynylsulfanyl]-3-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate	Investigative	44586989	C38H52O21S2	908.9	CC(=O)O[C@@H]1[C@H]([C@@H](O[C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)CO)SCC#CC3=CC=C(C=C3)C#CCS[C@@H]4[C@H]([C@@H]([C@H]([C@@H](O4)CO)O[C@@H]5[C@H]([C@@H]([C@@H]([C@@H](O5)CO)O)O)O)O)O)O	IC50 = 300000 nM	Non binder
T06320	Galectin 1	BSU02V	[(2S,3R,4R,5R,6R)-2-[3-[4-[3-[(2R,3S,4S,5R,6S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]sulfanylprop-1-ynyl]phenyl]prop-2-ynylsulfanyl]-3-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate	Investigative	44586989	C38H52O21S2	908.9	CC(=O)O[C@@H]1[C@H]([C@@H](O[C@@H]([C@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)CO)SCC#CC3=CC=C(C=C3)C#CCS[C@@H]4[C@H]([C@@H]([C@H]([C@@H](O4)CO)O[C@@H]5[C@H]([C@@H]([C@@H]([C@@H](O5)CO)O)O)O)O)O)O	IC50 = 300000 nM	Non binder
T06320	Galectin 1	BTY90X	Dimeric Galactoside	Investigative	44587042	C18H26O10S2	466.5	C(C#CC#CCS[C@@H]1[C@H]([C@H]([C@@H]([C@@H](O1)CO)O)O)O)S[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 3	BTY90X	Dimeric Galactoside	Investigative	44587042	C18H26O10S2	466.5	C(C#CC#CCS[C@@H]1[C@H]([C@H]([C@@H]([C@@H](O1)CO)O)O)O)S[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BV5PA7	(2R,3R,4R,5R,6S,E)-2-(Hydroxymethyl)-6-(prop-1-enyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586823	C9H16O5	204.22	C/C=C/[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	BV5PA7	(2R,3R,4R,5R,6S,E)-2-(Hydroxymethyl)-6-(prop-1-enyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44586823	C9H16O5	204.22	C/C=C/[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BV62PU	(2S,3R,4S,5R,6R)-2-((1-((2S,3S,4S,5R,6S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methylthio)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44587044	C21H35N3O15S	601.6	C1=C(N=NN1[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O)O)O)O)CS[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O	IC50 = 600000 nM	Non binder
T06320	Galectin 1	BV62PU	(2S,3R,4S,5R,6R)-2-((1-((2S,3S,4S,5R,6S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-((2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-yl)-1H-1,2,3-triazol-4-yl)methylthio)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol	Investigative	44587044	C21H35N3O15S	601.6	C1=C(N=NN1[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H](O3)CO)O)O)O)O)O)CS[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O	IC50 = 300000 nM	Non binder
T06320	Galectin 3	BVL8J4	5-(beta-D-Galactopyranosyl)-4-methyl-2-(4-methyl-phenyl)sulfonylaminothiazole	Investigative	44586892	C18H24N2O7S2	444.5	CC1=CC=C(C=C1)S(=O)(=O)NC2=NC(=C(S2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)C	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	BVL8J4	5-(beta-D-Galactopyranosyl)-4-methyl-2-(4-methyl-phenyl)sulfonylaminothiazole	Investigative	44586892	C18H24N2O7S2	444.5	CC1=CC=C(C=C1)S(=O)(=O)NC2=NC(=C(S2)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)C	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BW25OU	2-p-Bromobenzamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586952	C18H21BrN2O6S	473.3	CC1=C(SC(=N1)NC(=O)C2=CC=C(C=C2)Br)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 1	BW25OU	2-p-Bromobenzamido-5-(beta-D-galactopyranosyl)-4-methylthiazole	Investigative	44586952	C18H21BrN2O6S	473.3	CC1=C(SC(=N1)NC(=O)C2=CC=C(C=C2)Br)C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 = 2500000 nM	Non binder
T06320	Galectin 3	BWPV63	5-(beta-D-Galactopyranosyl)-4-methyl-2-p-nitro-benzamidothiazole	Investigative	44586950	C18H21N3O8S	439.4	CC1=C(SC(=N1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-])C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	BWPV63	5-(beta-D-Galactopyranosyl)-4-methyl-2-p-nitro-benzamidothiazole	Investigative	44586950	C18H21N3O8S	439.4	CC1=C(SC(=N1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-])C[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 1	BYF6G7	(E)-Methyl 2-phenyl-4-(beta-D-galactopyranosyl)-but-2-enoate	Investigative	25022444	C17H22O7	338.4	COC(=O)/C=C(\\C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)/C2=CC=CC=C2	IC50 = 313000 nM	Non binder
T06320	Galectin 3	BYF6G7	(E)-Methyl 2-phenyl-4-(beta-D-galactopyranosyl)-but-2-enoate	Investigative	25022444	C17H22O7	338.4	COC(=O)/C=C(\\C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)/C2=CC=CC=C2	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	BZMQ01	1-((2S,3R,4R,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)propan-2-one	Investigative	23651530	C9H16O6	220.22	CC(=O)C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 = 5000000 nM	Non binder
T06320	Galectin 1	BZMQ01	1-((2S,3R,4R,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)propan-2-one	Investigative	23651530	C9H16O6	220.22	CC(=O)C[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O	IC50 > 5000000 nM	Non binder
T06320	Galectin 3	D0D0BJ	D-galactose	Investigative	439357	C6H12O6	180.16	C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O	IC50 = 50000000 nM	Non binder
T06320	Galectin 1	D0D0BJ	D-galactose	Investigative	439357	C6H12O6	180.16	C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O	IC50 = 50000000 nM	Non binder